Our data show that the expression of GPNMB on the cell surface marks the quiescent phenotype and exhibits invasive and therapy-resistant features together with a significant negative correlation with KI67 levels in metastatic melanoma patients. The gene discussed is MKI67; the disease is metastatic melanoma.